仙乐健康：筹划发行H股股票并在香港联交所上市

Group 1 - The core viewpoint of the article is that Xianle Health (300791.SZ) plans to issue overseas listed foreign shares (H-shares) and apply for listing on the main board of the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 2 - The company aims to leverage the advantages of international capital markets to create a diversified capital operation platform [1] - The initiative is intended to accelerate the development of overseas business and improve the domestic and international dual circulation pattern [1] - This move is expected to strengthen the company's competitive position within the industry [1]